Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA

The company says the observations are procedural in nature.

Dec 19, 2025 - 10:00
 0  12
Aurobindo Pharma subsidiary’s plant in Andhra Pradesh issued five observations by U.S. FDA
The company says the observations are procedural in nature.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow